OpenVSafe by OpenVAERS
Search V-safe

FEE-21607-45425

3 vaccinations 5 coded responses 13 check-ins 5 free-text entries 3 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
070 / NJ
Registered
2021-01-04
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
V5J-31901-83844 Child or adolescent in my care · Female · 2021-12-04

Timeline

  1. 2020-12-23
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-04
    Registered in v-safe
  3. 2021-01-04
    Survey response — day 7, dose 1
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Supraclavicular lymphadema
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-13
    Dose 2 — Pfizer-BioNTech
  5. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-01-14
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  7. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  8. 2021-01-15
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  9. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea
    Adult check-in
  10. 2021-01-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Free text: Supraclavicular and axillary lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: Axillary and supraclavicular lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-22
    Survey response — day 7, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Free text: Supraclavicular lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-01-29
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  14. 2021-02-12
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-13
  16. 2021-02-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-28
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-11-30
    Dose 3 — Pfizer-BioNTech
  19. 2022-01-13
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2022-06-02
    Survey response — 6 months, dose 3
    MedDRA: COVID-19, Ear infection, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Ear infection Fever Covid
    MedDRA releases: 2024-11 · check-in free text available
  21. 2022-06-02
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  22. 2022-06-03
  23. 2022-06-06
  24. 2022-06-06
  25. 2022-06-06
  26. 2022-06-06

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Pfizer-BioNTech
22021-01-13Pfizer-BioNTech
32021-11-30Pfizer-BioNTech No

Call center

3 call center cases

3 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 1 — day 7, dose 1

2021-01-04

Systemic reaction (other): Supraclavicular lymphadema

Release 2 — days 1–6 daily, dose 2

2021-01-17

Systemic reaction (other): Supraclavicular and axillary lymphadenopathy

2021-01-18

Systemic reaction (other): Axillary and supraclavicular lymphadenopathy

Release 2 — day 7, dose 2

2021-01-22

Systemic reaction (other): Supraclavicular lymphadenopathy

Release 11 — 6 months, dose 3

2022-06-02

Symptoms: Ear infection Fever Covid

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDEar infection · · ✓
SDPyrexia · · ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…